We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNX icon
476
CNX Resources
CNX
$5.29B
$146M 0.03%
10,862,760
+10,816,452
+23,358% +$127M
SCHW
477
Charles Schwab
SCHW
$189B
$144M 0.03%
5,707,962
+3,044,509
+114% +$86.5M
SWX icon
478
Southwest Gas
SWX
$6.68B
$144M 0.03%
1,830,918
-30,102
-2% -$2.08M
KR icon
479
Kroger
KR
$34.3B
$143M 0.03%
3,896,019
+1,844,851
+90% +$66.4M
WEX icon
480
WEX
WEX
$6.48B
$143M 0.03%
1,612,426
+334,325
+26% +$29.8M
RH icon
481
RH
RH
$3.41B
$142M 0.03%
4,961,448
-404,840
-8% -$14.5M
CHS
482
DELISTED
Chicos FAS, Inc.
CHS
$140M 0.03%
13,093,820
+3,259,420
+33% +$38.1M
LAZ icon
483
Lazard
LAZ
$4.24B
$140M 0.03%
4,695,915
+1,713,248
+57% +$59.4M
TWLO icon
484
Twilio
TWLO
$37.9B
$138M 0.03%
+3,915,819
New +$121M
GIS icon
485
General Mills
GIS
$20.4B
$138M 0.03%
1,930,833
-13,245
-0.7% -$843K
YUM icon
486
Yum! Brands
YUM
$41B
$137M 0.03%
2,297,764
+460,089
+25% +$27.1M
ONCE
487
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$136M 0.03%
2,658,187
+145,580
+6% +$6.22M
GWR
488
DELISTED
Genesee & Wyoming Inc.
GWR
$135M 0.03%
2,290,345
-802,068
-26% -$49.1M
POOL icon
489
Pool Corp
POOL
$7.25B
$134M 0.03%
1,426,503
+127,114
+10% +$11.4M
BMI icon
490
Badger Meter
BMI
$3.91B
$134M 0.03%
3,670,018
-31,640
-0.9% -$1.13M
IPCC
491
DELISTED
Infinity Property & Casualty C
IPCC
$133M 0.03%
1,652,111
-700
-0% -$54.6K
LPLA icon
492
LPL Financial
LPLA
$29.7B
$133M 0.03%
5,912,398
-868,979
-13% -$21.8M
SWN
493
DELISTED
Southwestern Energy Company
SWN
$132M 0.03%
10,522,730
+9,725,310
+1,220% +$118M
BSAC icon
494
Banco Santander Chile
BSAC
$16B
$131M 0.03%
6,760,960
+3,195,125
+90% +$60.4M
PGRE
495
DELISTED
Paramount Group
PGRE
$130M 0.03%
8,179,130
+1,456,600
+22% +$23.7M
KMPR icon
496
Kemper
KMPR
$1.56B
$130M 0.03%
4,185,688
+147,661
+4% +$4.6M
MNST icon
497
Monster Beverage
MNST
$90.1B
$130M 0.03%
9,677,244
-112,380
-1% -$1.36M
MSA icon
498
Mine Safety
MSA
$7.41B
$129M 0.03%
2,453,960
-12,080
-0.5% -$598K
WDR
499
DELISTED
Waddell & Reed Financial, Inc.
WDR
$128M 0.03%
7,457,389
-58,254
-0.8% -$1.19M
WABC icon
500
Westamerica Bancorp
WABC
$1.38B
$128M 0.03%
2,592,178
-1,300
-0.1% -$62.9K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.